NCT07465757
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07465757
Title A Study of Alisertib and Paclitaxel in Patients With Small Cell Lung Cancer (SCLC) (ALISCA-Lung2)
Acronym ALISCA-Lung2
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Puma Biotechnology, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | ESP


No variant requirements are available.